NCT07196488Recruiting
Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses
Development and Exploring the Efficacy of a Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses
Source: ClinicalTrials.gov · Last updated 19 May 2026
Brief summary (registry, in English)
This study aims to help patients with prostate cancer and their spouses cope better with the challenges of cancer by learning and supporting each other together. The investigators will test an 8-week "Dyadic Co-learning Intervention," which includes weekly learning topics, a mobile app, and professional support. The goal is to improve their physical symptoms, emotional well-being, and resilience. Participants will be randomly assigned to one of two groups. One group will receive regular care, while the other group will receive regular care plus the new co-learning program. The investigators will ask both patients and their spouses to complete questionnaires at the beginning of the study, and again at 10 and 16 weeks, to understand how the program affects their health and well-being.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 6 Sept 2025
- Start date
- Oct 2025
- Primary completion date
- Jul 2026
- Lead sponsor
- National Taipei University of Nursing and Health Sciences
- Diseases
- Prostate cancer
- NCT number
- NCT07196488
What you commit to
- Study type: Interventional
- Planned participants: 60
- From Oct 2025 to the primary completion date, Jul 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosed with another type of cancer.
- Diagnosed with cognitive impairment or a psychiatric disorder, such as dementia, depression, or anxiety.
Other
- Either the patient or the spouse will be excluded if:
Who the study is looking for
- For Patients:
- Diagnosed with prostate cancer by a board-certified urologist.
- Has either decided on a treatment plan or completed treatment within the past two years.
- Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.
- For Spouses:
- Must be a cohabiting spouse of the prostate cancer patient and aged 20 years or older.
- Must have a Barthel Index score of 91 or above, indicating good functional independence.
Age in the registry: 20 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Keelung Chang Gung Memorial Hospital Coordinator of this site? Confirm its status | Keelung | Taiwan | Not yet recruiting |
| Linkou Chang Gung Memorial Hospital Coordinator of this site? Confirm its status | Taoyuan | Taiwan | Recruiting |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.